Supernumerary nipples (syn. accessory nipples)

LAST UPDATED: Nov 19, 2021

Introduction

A supernumerary nipple is a common, minor malformation of mammary tissue resulting in an extra nipple/s, and/or associated tissue. Most supernumerary nipples do not cause symptoms or complications.

This chapter is set out as follows:


Aetiology

  • Supernumerary nipples (or breasts) are found in up to 6% of the population
  • Most cases are sporadic, however, they are occasionally familial with an autosomal dominant pattern of inheritance with incomplete penetrance. Uncommonly, they are associated with genetic syndromes

History

  • Present at birth 

Clinical findings

  • Most are much smaller than the normal areola and nipple. They may be solitary or multiple, arising on one or both nipple line(s)
  • Lesions may be pink or brown, the central nipple is elevated off the skin surface
  • If the supernumerary nipple contains glandular tissue, it can enlarge during puberty, swell, and become tender premenstrually, and undergo lactation

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Management

Most people do not need treatment. Removal via surgery or another technique may be considered for cosmetic purposes or if there are symptoms that cause discomfort, such as lactation or tenderness.

A thorough work-up for other malformations typically is not needed in a person with a supernumerary nipple who is otherwise healthy. However, a work-up may be recommended if a person has any of the following (refer to the Genetic and Rare Disease Information Centre for more information):

  • A supernumerary nipple accompanied by additional minor malformations
  • A prominent ectopic (abnormally positioned) supernumerary nipple
  • An established family history of supernumerary nipples

Supernumerary nipples can undergo similar disease processes to normal breast tissue, and patients with glandular tissue require physical exams and mammography at the frequency recommended for normal breast tissue. 


Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco